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Some years ago, a series of human serum lipoproteins, distinguishable by 
their hydrated densities and l ipid-protein ratios were recognized and isolated 
by ultracentr i fugal  techniques (1). Certain of these l ipoproteins are invar iably 
present in human serum and the concentrat ions of these and of others can be 
quant i tat ive ly  correlated with disease (2). No difference in the l ipoprotein 
distr ibution can be demonstrated between serum and plasma. The purpose of 
this invest igat ion was to obtain information about  the immunochemical  speci- 
ficity of some of the l ipoproteins. 
Methods 
Preparation of Lipoproteinsl.--All ipoproteins, unless it is otherwise indicated, were 
isolated from pooled plasma. The plasma was obtained from citrated blood which was rejected 
by the San Francisco Blood Bank because of blood clots, positive serologic tests for syphilis, 
or because 3 weeks or more had elapsed since it was drawn. Between 8 and 16 pints of blood 
were used per pool. 
Low density lipoproteins SI6 and SI13 were isolated by the method of Lindgren et al. (3). 
The ultracentrifugal homogeneity of similar preparations has been discussed (5). The hy- 
drated density of Ss6 lipoproteins i  between 1.03 and 1.04 gm./ml, and that of Sjl3 lipo- 
proteins between 1.015 and 1.03 gm./ml. In Fig. 1 ultracentrifuge r cords of lot" density 
lipoprotein preparations are presented3 These lipoproteins were used as immunizing antigens 
* This work was supported in part by the Life Insurance Medical Research Fund and the 
United States Public Health Service. 
:~ Present address: Gates and Crellin Laboratories of Chemistry, California Institute of 
Technology, Pasadena. 
1 The lipoprotein omenclature that will be used throughout is that suggested by Lindgren 
et al. (3) for lot" density lipoproteins (lipoproteins of hydrated density less than 1.063 gm./ 
ml. and that suggested by deLalla and Gofman (4) for high density lipoproteins (lipoproteins 
of hydrated ensities 1.07 to 1.16 gm./ml.) 
2 Ultracentrifuge analyses were made with a Spinco model E analytical ultracentrifuge 
at a density of 1.063 gm./ml., 26°C. and a rotor speed of 52,640 R.P.M. (average distance 
from center of rotation is 6.5 cm.). Only one frame for each preparation, 30 minutes after 
full rotor speed was attained, is reproduced. No evidence of lipoproteins can be seen in any 
of the other frames that cannot be seen in the frame shown. The complete records have been 
presented elsewhere (6). Two preparations were always run simultaneously; some of them 
were not used in the experiments described but have not been removed from the ultracen- 
trifuge records. 
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F. ALADfEM~ M. LIEBERMAN~ AND J. W. GOFMAN 51 
(see below). An analysis of the ultracentrifuge r cords of the various Sf6 and Sf13 prepa- 
rations (4) indicated the amount of material common to the two types of preparations to be 
less than 1 per cent of the total ipoprotein concentration. I  the $t6 preparations there were no 
measurable ipoproteins of flotation rates greater than SI8 or less than $t4, except for one 
preparation that had less than 1 per cent of total lipoprotein between St8 and 11. In the Ss13 
preparations there were in no case measurable concentrations of llpeproteins offlotation rates 
above St16 or below S/11. 
Ss17-[- was the designation given to material collected in the top 0.5 ml. from unaltered 
plasma that was centrifuged in the preparative Spinco ultracentrifuge, model L, at 30,000 
1.P.K., 26°C., for 24 hours in a Spincu No. 30 rotor. The hydrated ensity of this material was 
less than 1.015 gm./ml.; it contained principally SI20 to 40 lipoproteins and small amounts of 
material up to the chylomicron range. 
Two high density lipoprotein fractions were isolated, one of mean hydrated ensity 1.075 
gm./ml., which has been designated HDL-2 (4), and the other, of mean hydrated ensity 
1.145 gm./ml, which has been designated HDL-3. These fractions were isolated by the general 
method of deLalla and Gofman (4), except for the following modifications; ome of the low 
density lipoproteins were first separated by removing the floated lipoproteins after centri- 
fugation of unaltered plasma for 24 hours at 30,000 ~.P.M. in a preparative No. 30 rotor. Most 
of the remaining low density lipoproteins were then separated at density 1.063 gm./mL by 
repeated ultracentrifugation and removal of the floated llpoproteins, followed by dilution of 
the subnatant in sodium chloride solution of density 1.063 gm./ml. Five recentrifugations at 
density 1.063 gm./ml, were necessary to remove low density lipoproteins from a preparation 
containing HDL-2 and HDL-3 llpoproteins. Film analysis of this preparation i dicated that 
the final low density lipoprotein concentration was approximately 0.2 per cent of the total 
lipoprotdn concentration. 
Lipeprotein-free plasma protein fractions were prepared from the subnatants of tubes from 
which the high density llpoproteins were isolated. These subnatants were recentrifuged four 
times at density 1.21 gm./ml., 30 hours at 40,000 R.I,.M. each followed by the removal of 
the floated lipoproteins and dilution to the original volume with D20-salt solution of density 
1.21 gm./ml. 
Preparation of Antiserums.--Antiserums against low density lipoproteins were prepared by 
injecting subcutaneously 14 rabbits with Sl6 and 14 rabbits with 8113. Ultracentrifuge r cords 
of all the low density lipoprotein preparations that were used as immunizing antigens are 
presented in Fig. 1 and are marked SI6 and S/13, respectively. The rabbits received 10 in- 
jectious, (2 or 3 injections on successive days every 2 or 3 weeks) over a period of 2 months, 
about 10 rag. ]ipoprotein per injection. 8 days after the last injection the rabbits were bled. 
5 months later all rabbits received one more injection of lipoprotein and were again bled after 
8 days. All low density lipeprotein fractions were used within 2 or 3 days after isolation since 
they tended to form a small amount of insohble precipitate after standing a week or longer 
in the ice chest at 4°C. 
Antiserum against high density llpoproteins was prepared by injecting a lipoprotein prepa- 
ration containing HDL-2 and HDL-3. High density lipoproteins were found to be more stable 
to storage than low density lipoproteins since no insoluble precipitate developed uring several 
weeks at 4"C.; one preparation sufficed. Eight rabbits were injected subcutaneously with this 
preparation thrice weekly for 3 weeks, about 10 rag. lipoprotein per injection. The rabbits were 
bled 6 days after the last injection. 
Fra~tiona~ion f Antiserums.--Antiserums against low density lipoproteins and pooled 
normal rabbit serum were fractionated by repeated precipitation with half-saturated am- 
monium sulfate, followed by separation of the precipitate into the water-soluble pseudo- 
globulin and the water insoluble uglobulin fractions, as previously reported (7). The pseudo- 
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52 IMMUNOCHEMICAL STUDIES ON PLASMA LIPOPROTEINS 
globulin fractions of the anti-St6 serum pools are referred to asP-6, the euglobulin fractions as 
E-6. Corresponding designations are given to anti-S/13 serum fractions, P-13 and E-13. 
Salt Concentration f Precipitin Reactions.--Qualitative andquantitative precipitin re- 
actions were carried out at an ionic strength of approximately/~ -  0.1. To obtain this salt 
concentration, antiserum fractions were dialyzed but lipoprotein fractions were diluted with 
distilled water. They were not dialyzed since changes of lipoproteins upon dialysis have been 
observed (8). 
EXPERIMENTS AND RESULTS 
Tests for Cross-Reaction between Lipoproteins and Non-Lipide 
Containing Proteins 
Anti-lipoprotein serums and serum fractions were tested by precipitin tests 
with the following antigens: human serum albumin, human serum gamma 
globulin, and the subnatant of a 1.2 density ultracentrifuge run. No precipi- 
tate was detected with the first two antigens. I t  was found that the subnatant 
did precipitate with anti-lipoprotein serums. Mter four recentrifugations of 
the subnatant,  as described above, the last traces of lipoproteins were appar- 
ently removed and no more precipitate formed with anti-lipoprotein serums. 
None of the lipoprotein fractions precipitated with antiserums against hu- 
man albumin or human gamma globulin. 
Comparison of Lipoprotein Fractions from Different Individuals 
Serums from freshly drawn blood of seven presumably normal individuals, plasma from 5 
individual pints of blood hank blood, and plasma obtained by pooling 8 pints of blood bank 
blood (i.e. 13 samples) were used. We did not consider it necessary to employ the rather 
cumbersome isolation procedure described on the previous pages. The following simplified 
procedure was substituted:- 
The thirteen test samples were centrifuged in the preparative ultracentrifuge, 9 mL each, 
at 30,0001LP.~. for 24 hours, at 26°C. Four fractions were pipetted from each tube. 
(a) Fraction 1. The top 0.75 ml.; this fraction contained all the lipoproteins that had 
floated to the top of the tube. These were of S/17 and of higher $I rate, up to and including 
chylomicrons. The next 3.75 ml. of the clear layer beneath were discarded. This solution con- 
tained only very small amounts of lipoproteins, principally of Stl3 to 17. (b) Fraction 2. The 
next 1.0 mL; this contained most f he lipoproteins of $18 to 16. (¢) Fraction 3. The next 0.5 
ml.; this was the material just above the albumin boundary nd consisted of lipoproteins of 
S;,3 to 8 and a small amount of albumin. (d) Fraction 4. The next 1.5 ml.; this material con- 
tained albumin, globulin, and a large portion of high density llpoproteins It'DL-2 and HDL-3. 
The remaining 1.5 ml. was discarded. 
2 ml. of P-6 and 2 ml. of P-13 antiserum fractions from the second bleeding were frac- 
tionally absorbed with each of the four fractions from each of t e 13 samples until no more 
precipitate appeared within 48 hours. The absorbed antiserums were then tested with the 
corresponding fractions of every other samples and with the original sample as control. Un- 
absorbed antiserum fractions were used as another set of controls. 
I t  was found that once an antiserum preparation was absorbed with a lipo- 
protein fraction of any one individual, no further precipitation occurred with 
the same lipoprotein fractions of any other serum or plasma. No difference in 
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F. ALADJEM~ M. LIEBERMAN'~ AND J. W. GOFMAN 53 
specificity could be demonstrated for any one of the four lipoprotein fractions 
from twenty individuals. 
Comparison of Lipoprotein Fractions Isolated from One Plasma Pool 
Quah'tati~e Absorption Analyses.--Antiserum preparations P-6, E-6, P-13, and E-13 from 
the second bleeding and anti-(HDL-2 and HDL-3) serum were fractionally absorbed with 
lipoprotein antigens 8117+, SII3, SI6, HDL-2, and HDL-3. When no more precipitate ap- 
poared upon further addition of absorbing antigen, the absorbed antiserums and antiserum 
fractions were divided into five aliquots and each reacted with one of the five antigens. All 
the anti-low density lipoprotein preparations gave identical results and are presented as a 
TABLE I 
Reactions of Anti-Lipoprolein Serums with Isolated Lipoproteins before and after Absorption 
Antiserums or antiserum fractions 
1. P-6, E-6, P-13, E-13 
(a) Before absorption 
(b) After absorption with: $/17+ 
$/13 
S~6 
HDL-2 
HDL-3 
2. An~-(HDL-2 and 3) 
(a) Before absorption 
(b) After absorption with: $/17+ 
Syl3 
s~6 
HDL-2 
HDL-3 
tT+ 
+ 
+ 
+ 
+ 
+ 
Antigens 
Sst3 $# HDL-2 
+ + + 
+ + -- 
+ + + 
± + + 
+ + -- 
+ + + 
nT~L4 
+ 
+ 
+ 
+ 
+ 
group in Table I, together with the results using the anti-(HDL-2 and HDL-3) serum. The 
results are discussed below. Precipitation between low density lipoproteins and anti-(HDL-2 
and HDL-3) serum absorbed with HDL-2 is assumed to have been due to anti-low density 
lipoprotein antibodies present in this serum as a result of a small amount of low density lipo- 
protein contamination (,,~0.2 per cent) in the immunlz~ng antigen. 
Quantitative Precipitin Analyses.--Quantitative precipitin analyses were performed with 
St6 and Sy13 lipoprotein preparations and all antibody fractions. The details of the technique 
were reported previously (7). Normal rabbit serum and serum fractions were used throughout 
as controls. Cholesterol analyses were performed on some of the replleate precipitates and 
supernatants by the method of Colman and McPhee (9). It was uniformly found, in both the 
homologous and heterologous systems, that all the cholesterol added in the form of llpoprotein 
antigen was precipitated throughout the region of antibody excess. 
Results of quantitative precipitin analyses are given in Tables I I  to IX  and 
Figs. 2 to 5. Only data obtained with antiserum fractions from the first bleeding 
and lipoprotein preparations obtained from one plasma pool are given here. 
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54 n.qMUNOCI :~.MICAL  STUDIES  ON PLASMA L IPOPROTEINS 
Those from the second bleeding were essentially the same and have been pre- 
sented in detail elsewhere (6). 
Agar Di~usion Analysea.--The agar diffusion technique was performed as described by 
Oudin (10). The pH of all reaction mixtures was adjusted to7.1. Tubes were observed for 20 
TABLE II 
Addition of Increasing Amounts of Ss6 to Anti-St6 Rabbit Pseudoglobulin 
S.t6 N added 
rag. 
0.0O77 
0.0153 
0.0191 
0,0229 
0.0306 
0.0383 
0.0478 
0.0574 
0.0765 
0.0956 
0.1148 
0.1339 
0.1530 
0.1721 
Total N ppt. 
0.0175 
0.049 
0.0665 
0.0805 
0.106 
0.1225 
0.1365 
0.1475 
0.1435 
0.1225 
0.0735 
0.0525 
0.0385 
0.000 
1.0 nil. antiserum fraction per tube 
Antibody N by 
difference 
rag. 
0.0099 
0.0337 
0.0474 
0.0576 
0.0754 
0.0843 
0.0887 
0.0901 
Ratio ant ibody 
N:  lipoprotein N 
in ppt. 
1.29 
2.20 
2.48 
2,51 
2.46 
2.20 
1.86 
1.57 
Tests oa 
supernatant 
Not doue 
TABLE II I  
Addition of Increasing Amounts of SsI3 to Anti-St6 Rabbit Pseudoglobulin 
1.0 nil. antiserum fraction per tube 
S j  13 N added 
mg. 
0.0073 
0.0145 
0.0242 
0.0483 
0.0724 
0.0967 
0.121 
0.145 
0.169 
0.1932 
0.2175 
0.2415 
Total N ppt. 
mg. 
0.0326 
0.0466 
0.0606 
0.0933 
0.1167 
0.1352 
0.1493 
0.1493 
0.1352 
0.1167 
0.0886 
0.0513 
Anf ibodyNby 
d~er~ce  
mg. 
0.0254 
0.0321 
0 .~ 
0.045 
0.0443 
Ratio 
antibody 
N:Upoprotela 
Nh  ppt. 
3.50 
2.21 
1.51 
0.932 
0.613 
Tests on supernataat 
Excess antibody 
cc ~ 
~c c~ 
No antibody, no antigen 
~¢ ¢¢ cg ¢¢ 
Excess antigen 
eL ¢¢ 
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F. ALADJEM~ M. LIEBP.RMAN~ AND J. W. GOFMAN 
TABLE IV 
A ddition of Increasing Amounts of S f6 to Anti-Syl3 Rabbit Pseudoglobulin 
55 
$16 N added 
mg. 
0.0061 
0.0092 
0.0122 
0.0153 
0.0184 
O. 0245 
0.0306 
0.0383 
0.0459 
0.0612 
0.0765 
0.0918 
O. 1071 
O. 1224 
0.1530 
O. 2448 
Total N ppt 
mg. 
0.0252 
O. 0364 
0.0448 
0.0533 
0.070 
0.0756 
0.0890 
0.101 
O. 1065 
O. 070 
0.0448 
0.0336 
0.0196 
0.0084 
O. 0056 
0.0028 
1.0 ml. antiserum fraction per tube 
Antibody N by 
difference 
mg. 
0.0191 
0.0272 
0.0326 
0.038 
0.0516 
0.0511 
0.0590 
0.0628 
Ratio 
an~bodyN; 
lipoprotein 
N inppt. 
3.12 
2.97 
2.66 
2.48 
2.81 
2.09 
1.93 
1.64 
Tests on supernatant 
Excess antibody 
No antibody, no antigen 
Excess antigen 
t¢ t t  
TABLE V 
A~ition ~IncreasingAmounts ~13toAnti-~13RabbitPseudoglob~ 
S/13Naddod 
mS. 
0.0054 
0.0190 
0.0182 
0.0272 
0.0363 
0.0543 
O. 0725 
0.0906 
0.1089 
0.127 
0.145 
0.1815 
Total N ppt. 
~g.  
0.0175 
0.0315 
0.049 
0.0665 
0.084 
0.1018 
0.105 
0.084 
0.070 
0.042 
0.028 
0.0105 
1.0 ml. antiserum fraction per tube 
Antibody N by 
difference 
rag. 
0.0121 
0.0206 
O. 0309 
0.0393 
0.0477 
O. 0475 
l~tio 
ant ibody  N: 
li~)oprotein 
N in ppt. 
2.22 
1.89 
1.70 
1.44 
1.31 
0.87 
Test  on  supernatant  
Excess antibody 
No antibody, no antigen 
cc gc cc cc 
Excess antigen 
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56 TMACENOCWRAfrCAL SI'uDIES ON PLASMA LIPOPROTEINS 
TABLE VI 
Addition of Increasing Amounts of 3f6 to Anti-S! 6 Rabbit Euglobulin 
8~ ~ added 
mg. 
0.0031 
0.0061 
O. 0092 
0.0122 
0.0153 
0.0186 
0.0214 
0.0245 
0.0306 
O. 0459 
0.0612 
0.0765 
0.0918 
O. 1071 
O. 1836 
Total N ppt. 
mg. 
0.0336 
0.0532 
0.0617 
0.0729 
O. 0841 
0.0954 
O. 1036 
0.1149 
O. 126 
0.0756 
0.0392 
0.0224 
0.0112 
0.0112 
0.0056 
1.0 ml. antiserum fraction per tube 
Ratio 
Antibody N by antibody N:
difference lil~oprotein 
N in ppt. 
~g.  
O. 0305 9.98 
0.0471 7.69 
0.0525 5.72 
0.0607 4.86 
0.0688 4.50 
0.0770 4.20 
0.0822 3.84 
0.0904 3.69 
0.0954 3.12 
Tests on supernatant 
Excess antibody 
No antibody, no antigen 
g¢ ¢¢ ¢¢ el  
(tt ¢¢ ~¢ ¢¢ 
¢¢ ¢¢ ¢¢ ¢¢ 
¢¢ ¢~ Ot (¢ 
¢¢ ¢¢ (¢ (¢ 
Excess antigen 
TABLE VII 
Addition of Increasing Amounts of St 13 to Anti-St 6 Rabbit Euglobulin 
3113 N added 
m&. 
0.0073 
0.0109 
0.0145 
0.0182 
0.0236 
0.029 
0.0363 
0.0453 
0.0544 
0.0725 
0.0906 
O. 1088 
O. 145 
Total N ppt. 
mg. 
o.o2~ 
0.0385 
0.049 
0.056 
0.0735 
0.0875 
O. 105 
0.119 
0.0945 
0.0525 
0.028 
0.021 
0.014 
1.0 ml. antiserum fraction per tube 
Ratio 
Antibody N by antibody N:
difference l iL)ourotein 
N in ppt. 
mg. 
O. 0208 
0.0241 
0.0345 
0.0379 
0.0499 
0.0686 
0.0688 
0.0737 
2.86 
2.22 
2.38 
2.09 
2.11 
2.01 
1.90 
1.63 
Tests on supernataat 
Excess antibody 
(¢ ¢¢ 
No antibody, no ~tEgm 
l~ (¢ g l  ¢1 
Cg I¢ ¢g |t~ 
¢1~ 1¢ ¢1 gg 
lg ¢¢ (~ Cg 
¢1 1¢ ¢¢ I~( 
Excess antigen 
 o
n
 August 22, 2006 
w
w
w
.jem.org
D
ow
nloaded from
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TABLE VIII 
Addition of Increasing Amounts of Sy 6 to Anti-Sf 13 Rabbit Euglobulin 
57 
S~6 N added 
mg. 
0.0022 
0.0044 
0.0066 
0.0088 
0.0109 
0.01313 
0.0153 
0.0175 
0.0197 
0.0219 
0.0328 
0.0438 
0.0547 
Total N ppt. 
mg. 
0.0020 
0.0086 
0.022 
0.0321 
0.0366 
O. 0441 
O. 050 
O. 058 
0.040 
0.028 
0.014 
0.0080 
0.0020 
1.0 ml. antiserum fraction per tube 
Antibody N by 
difference 
mg. 
0.0042 
0.0154 
0.0233 
0.0257 
0.0310 
0.0347 
0.0405 
Ratio 
antibody N: 
Li'popmtein 
N fil ppt. 
0.954 
2.35 
2.67 
2.35 
2.36 
2.27 
2.31 
Tests on supern~tant 
Excess antibody 
No antibody, no antigen 
sg [[ ~¢ cg 
Excess antigen 
TABLE IX 
Addiliou of I~:reaslng Amounts of S/13 :o An~S! 13 Rabbi~ Euglobulin 
$113 N added 
mg. 
0.0029 
0.0058 
0.0073 
O. 0087 
0.0102 
0.0116 
0.0145 
0.0159 
0.0174 
0.0203 
0.0232 
0.0261 
0.029 
0.0435 
0.058 
Total N ppt. 
mg. 
0.0084 
0.0196 
0.028 
0.0336 
0.0392 
0.0448 
0.0504 
0.056 
0.0672 
0.0728 
0.0784 
0.0672 
0.0448 
0.0112 
0.0112 
Antibody N by 
difference 
mg. 
0.0055 
0.0138 
0.0208 
0.0249 
0.0290 
0.0332 
0.0359 
0.0401 
0.0498 
0.0525 
L0 ml. antiserum fraction per tube 
Ratio 
ant ibody N:  
li~o~rotcin 
N in ppt. 
1.90 
2.34 
2.86 
2.86 
2.86 
2.86  
2 .48 
2.52 
2.86 
2.59 
Tests  on superngtaat  
Excess antibody 
No antibody, no antigen 
Excess antigen 
~ cg 
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days. Antibody preparations P-6, E-6, P-13, E-13 from the second bleeding, and anti-high den- 
sity lipoprotein serum, each in several concentrations, were reacted with the following anti- 
gens: whole serum, isolated SflT+, S~,13, Sf6, preparations of high density lipoproteins 
and a llpoprotein-free serum protein preparation; the latter was used as antigen control. 
All tubes containing anti-low density lipoprotein serum preparations gave 
essentially similar results; 6 to 8 bands were observed. However, these bands 
did not develop in succession, at the leading edge of precipitation. Rather, a 
precipitation zone formed first. The boundary of this zone moved. Mter 5 days, 
0.15  
C3 
I.IJ 
n 
Z 0.10 
~ 0.05 
i i i 
60 
! 
& 
t 
0 0.05 0.10 035 
MILLIGRAMS ANTIGEN NITROGEN ADDED 
0.20 
Fzo. 4. Addition of increasing amounts of • • • S/6 to anti-Sf6 rabbit euglobulin, Table VI 
and O O O SI13 to anti-S/6 rabbit euglobulin, Table VII. 
within this zone of precipitation, one band was clearly distinguishable and 
after 7 days 6 bands could be recognized, all within the zone of precipitation. 
Toward the end of the observation period there were usually 8 bands. Details, 
like the time of appearance of the bands and the rates of migration were, of 
course, dependent upon the particular conditions of the experiment, primarily 
antigen-antibody ratio and concentration, and the temperature of incubation. 
Fig. 6 indicates the migration of the leading boundary of 2 concentrations 
of E-6, and whole serum as antigen. This result is representative for the low 
density lipoprotein antigen-antibody system. 
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F. ALADJEM, M. LIEBERMAN, AND 3. W. GOldMAN 61 
When agar diffusion tubes were centrifuged at 1000 g.P.~, for a few m;nutes, 
some of the precipitates which appeared as bands floated to the top of the tube, 
while others edimented. 
The migration of bands upwards, into the antigen layer, was observed at 
certain antigen-antibody ratios, or when sufficient amounts of S/17 and higher 
Sf llpoproteins were present. 
,=,, 
I'~ 0.10 -- 
..j 0 .05  
o 
0.05  0. I0  
MILL IGRAMS ANTIGEN N ITROGEN ADDED 
Fzo. 5. Addition of increasing amounts of • • • S/6 to anti-S113 rabbit euglobuIin, Table 
VIII and OOO St13 to anti-St13 rabbit euglobulin, Table IX. 
With Sf 17-{-, 13 and 6 lipoprotelns and anti-high density lipoprotein serum, 
a precipitation zone was observed and within this zone bands appeared. The 
zone and bands were of the same type as those observed with the anti-low 
density tipoprotein serum fractions. However, when isolated high density 
lipoprotein fractions or whole serum were used as antigen, the results were 
different. For about 10 days there was only one zone of precipitation. Then one 
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new zone became recognizable, as indicated in Fig. 6. This zone also formed 
within the zone of precipitation but was broad and very different in appearance 
from the bands that were observed with the isolated low density lipoprotein 
antigens. No band formation analogous to what was described above was ob- 
served here. Interpretations of these findings will be discussed below. 
DISCUSSION 
The immunochemical homogeneity of a number of different lipoprotein prepa- 
rations has been examined by absorption, precipitin, and agar diffusion tech- 
niques. 
Qualitative absorption tests showed that either of the low-density lipopro- 
teins, $I 6 or Ss 13, can absorb all the precipitating antibodies of both the 
homologous and heterologous antiserums and antiserum fractions. The data 
summarized in Table I suggest hat ]ipoproteins have the following minimal 
antigenic ompositions: Low density fipoproteins SI 6 and Sf 13 contain a set of 
antigens different han HDL -2 and HDL -3. High density lipoproteins HDL 
-2 contain at least two antigenic omponents, one of which is also present in 
low density lipoproteins. Neither component is present in HDL -3. High density 
lipoproteins HDL -3 contain at least one antigenic omponent which is not 
present in any other lipoprotein. 
Quantitative precipitin analyses confirmed the close immunochemical 
similarity of SI 6 and $I 13 lipoproteins. Three criteria of immunochemical 
homogeneity (II) have been met for these systems: Lipoproteins did not cross- 
react with non-lipide--containing plasma proteins; in no instance were both 
antigen and antibody present in the same supematant; antigen added was 
completely precipitated throughout the region of antibody excess. Cholesterol 
analyses of precipitates and supernatants confirmed these findings. 
In precipitin systems containing the pseudoglobulin antiserum fractions 
P-5 or P-13, the amount of lipoprotein itrogen necessary to precipitate the 
maximum amount of antibody nitrogen was essentially the same, whether S! 6 
or Sf 13 were used. To reach the point of maximum precipitation with $I 6 re- 
quired only slightly more lipoprotein itrogen than was necessary to precipitate 
the maximum amount of antibody. With SI 13, however, maximum amount of 
precipitation required two or three times the quantity of antigen that suificed 
for precipitation of maximal amounts of antibody nitrogen. This was found 
to be the case with the homologous as well as the heterologous antiserum 
fractions. In systems containing euglobulin antiserum fractions E-6 or E-13, 
the antigen concentrations at which the maximum amount of antibody pre- 
cipitated coincided with that at which the maximum amount of total precipi- 
tate formed. But again, more $t 13 nitrogen was required than Sf 6 nitrogen. 
Although it is known that the ratio of SI 6 nitrogen to Ss 13 nitrogen is about 
1.2 (12), the lower nitrogen content of Sz 13 cannot account for the observed 
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differences in nitrogen precipitated unless one makes a~bitrary assumptions 
about he configurations of the llpoproteins. The antigen-antibody ratios with 
euglobulin antibody fractions were higher than the corresponding ratios with 
the pseudoglobulin antibody fractions. A similar observation has been pre- 
viously reported for the ovalbumin- rabbit antiovalbumin system (7). 
Since Kunkel (13) demonstrated antigenicity ofhuman plasma lipoproteins, 
precipitin analyses with lipoproteins have been reported by Gitlln (14) and, 
while this manuscript was in preparation, by Levine eta/. (15). Gitlin studied 
the precipitin behavior of ~-lipoproteins i olated by Oncley's method (16). He 
found that fl-llpoproteins i olated from three different plasma pools precipi- 
tated differently. On the basis of this result and the finding of multiple bands 
by the agar diffusion procedure, he concluded that ~-lipoproteins are immuno- 
chemically markedly heterogeneous. This conclusion would appear to lead to 
the further conclusion, that the plasma pools, from which fl-lipoproteins were 
isolated, contained varying amounts of immunochemically different lipopro- 
teins. However, the plasma pools were derived from 100 or more pints of blood 
(17). In the light of what is presently known about he lipoprotein distribution 
in the human population (18)---as determined by ultracentrifugal methods'-- 
large pools would be expected to be of nearly identical lipoprotein composition. 
It is suggested that results like those reported by Gitlin could have been ob- 
tained with lipoprotein preparations obtained from one pool, i.e., even with 
identical starting material, had there been slight differences in the method of 
preparation of the fl-lipoproteins. Levine et al. (15) reported complement 
fixation and quantitative precipitin analyses of low density lipoproteins. Their 
quantitative precipitin analyses confirmed our previous report (19) that either 
of the low density lipoprotein antigens, S I 6 and Sf 13, can absorb all the pre- 
cipitating antibodies from the homologous and heterologous antiserums or 
antiserum fractions, that there are considerable differences in the precipitin 
curves when different lipoprotein antigens are used with any one antiserum, 
and that analyses of precipitates for cholesterol indicated that all the lipopro- 
tein antigen was precipitated throughout the region of antibody excess. Levine 
eta/. concluded that their antiserum did not differentiate between four low 
density lipoprotein preparations. Actually, their quantitative precipitin data 
do appear to show differences between the heterologous and homologous sys- 
tems, both in quantity of antibody precipitated, aswell as the amount of anti- 
gen necessary to reach equivalence and antigen excess. These differences were 
even greater than the ones we have found; our antigen/antibody ratios were 
of the same order of magnitude as those reported by Levine eta/. 
The interpretation f the agar diffusion data presents some ditficulty. Using 
the Oudin technique, Gitlin (14) observed 6 to 8 bands. Korngold and Lipari 
(20), employing the Ouchterlony modification of the agar diffusion technique 
(21), found only one band between antiserum prepared against lyophilized 
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fraction III (Cohn's procedure 6) and antigen obtained by "centrifuging frac- 
tion I + II + I I I  at density less than 1.063." They suggested that material 
other than lipoprotein may have been responsible for the multiple bands ob- 
served by Gitlin. Levine et a/. also used the Oudin procedure and observed 
several zones of precipitation between low density tipoprotein preparations 
and anti-low density lipoprotein serum. They reported that some of the bands 
were caused by other than lipoprotein systems. After absorbing their antiserum 
with a Upoprotein-free plasma solution, they found only one band between a
low density lipoprotein preparation and the absorbed antiserum. This was 
interpreted to indicate that only one antigen-antibody s stem was present. 
We have two reservations concerning this interpretation: (a) their method of 
preparation of the lipoprotein-free plasma solution probably failed to provide 
for complete removal of lipoprotdns, and (b) the time of observation of diffu- 
sion in the agar tubes might have been too short for the development of mul- 
tiple bands. Lipoprotein-free plasma was prepared by centrifuging plasma at 
density 1.063 gm./ml, for 16 hours at 100,000 g; the floated lipoproteins were 
removed and the subnatant recentrifuged atdensity 1.21 gm./mi, for 30 hours 
at 100,000 g. The subnatant was assumed to be lipoprotein-free plasma. In the 
present study we have found that at least two recentrifugations of the subna- 
rant at density 1.21 gm./ml., each followed by removal of the floated lipopro- 
reins, were necessary to remove all the lipoproteins which react with anti-low 
density llpoprotein serum. Failure to remove the small amount of high density 
lipoproteins that would presumably be present in the preparation would lead, 
when absorption with this material is carried out, to absorption of all those 
antibodies which cross-react with high density lipoproteins. As to the diffusion 
time, the reported time of Levine and his associates of observation of the agar 
tubes was only 4 days. It can be seen from Fig. 6 that band formation in the 
present study was not observed until after the 5th day. 
Since our antiserums did not precipitate with human serum alb,lmin, human 
serum gamma globulin or the lipoprotein-free protein fraction prepared from 
the subnatant of a 1.2 density run, it is conduded that the bands observed in 
our agar diffusion analyses were due to llpoprotein-antilipoprotein precipita- 
tions. Neither Gitlin nor Levine eta/. reported the peculiar type of band for- 
marion that we observed nor could we find any other report in the literature. 
Owen (22), applying the double diffusion technique (23) to a whole human 
serum-rabbit antiserum system, observed a similar phenomenon,--formation 
of a precipitation zone with subsequent development and migration of the 
bands within the zone. In both, his experiments and ours, temperature varia- 
tions were exduded as a possible source of error. 
The conclusion that lipoproteim move as a single component in an agar 
diffusion system (15, 20) must be reexamined. Although our work on agar 
diffusion does not permit a final conclusion, we are inclined to believe at this 
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time that each band really represents a distinct though closely related antigen- 
antibody system. 
On this assumption, our results suggest the following antigenic composition 
of lipoproteins: hpoproteins of highest hydrated density, HDL-3, are antigeni- 
cally distinct from all other lipoproteins. HI)L-2 contain several antigenic 
components, at least one peculiar to HDL-2, others in common with low den- 
sity hpoproteins. Continuing the hydrated density scale of lipoprotcins towards 
lower densities, new antigenic components become apparent. Low density 
lipoproteins S! 6 and $I 13 contain at least 6 or 8 components. It might be 
expected that in lipoproteins of still lower hydrated density additional antigenic 
components may be present, but that some of those associated with St 6 or 
S! 13 might be absent. This type of distribution might be thought to exist for 
lipoproteins up to the chylomicron range. 
The basic reason that the reported experiments did not permit dearer 
separation of antigenic components of hpoproteins might have been the use, 
throughout this work, of antiserums prepared in the rabbit. This animal's 
antibody-producing mechanism may be unable to distinguish subtle antigenic 
differences of materials of human origin. The production of anti-human hpo- 
protein serums in primates (other than man) might yield much more definitive 
results. 
SUMMARY 
Low density human plasma lipoproteins S/17-{-, S/13, and S/6, high density 
lipoproteins 2 and 3, and a lipoprotein-free plasma protein fraction were iso- 
lated from human plasma by ultracentrifugal methods. It was found that 
human plasma lipoproteins are immunochemically distinct from the non- 
lipoprotein containing plasma protein fraction. 
Lipoprotein fractions of a given hydrated density, isolated from different 
individuals, were found to be immunochemically indistinguishable by quali- 
tative absorption tests. 
Qualitative antigenic differences were shown to exist between low density 
lipoproteins and high density lipoprotcins. 
Quantitative precipitin reactions showed that low density lipoproteins $I 6 
and S/13 were immunochemically very similar. However, they differed with 
respect to the amount of antigen itrogen required for maximum precipitation. 
Agar diffusion analyses were performed; the results suggest heterogeneity 
of lipoproteins by this criterion. 
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